This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Joanna Hemming Taylor, PhD
Associate Principal Scientist at AstraZeneca
Speaker

Profile

Joanna Hemming Taylor graduated with a MChem in Chemistry from the University of Manchester in 2009, followed by a PhD in biophysical and computational chemistry from University College London with an emphasis on characterisation of lipids and peptides at the air-liquid interface. In 2014 Joanna joined AstraZeneca and has worked as an analytical project lead on multiple early phase clinical projects, from small molecule therapeutics to larger synthetics such as peptides and drug-dendrimer conjugates. More recently, Joanna has been responsible for leading the analytical development and control strategy of siRNA projects within Early Chemical Development.